The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Growing patent filings and tier-2 innovators reflect expanding national research base
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
Subscribe To Our Newsletter & Stay Updated
